All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
FDMT / 4D Molecular Therapeutics, Inc.
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AMRS / Amyris Inc
|
|
|
|
|
|
|
|
/ Nautilus Biotechnology Inc
|
|
|
|
|
|
|
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
DNA / Ginkgo Bioworks Holdings, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
ME / 23andMe Holding Co.
|
|
|
|
|
|
|
|
TPTX / Turning Point Therapeutics Inc
|
|
|
|
|
|
|
|
US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
TKNO / Alpha Teknova, Inc.
|
|
|
|
|
|
|
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
FHTX / Foghorn Therapeutics Inc.
|
|
|
|
|
|
|
|
MASS / 908 Devices Inc.
|
|
|
|
|
|
|
|
ALEC / Alector, Inc.
|
|
|
|
|
|
|
|
CLOV / Clover Health Investments, Corp.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SEER / Seer, Inc.
|
|
|
|
|
|
|
|
DBTX / Decibel Therapeutics Inc
|
|
|
|
|
|
|
|
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
GBIO / Generation Bio Co.
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CDAK / Codiak Biosciences Inc
|
|
|
|
|
|
|
|
IPSC / Century Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CDNA / CareDx, Inc
|
|
|
|
|
|
|
|
NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
BLI / Berkeley Lights Inc
|
|
|
|
|
|
|
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ADPT / Adaptive Biotechnologies Corporation
|
|
|
|
|
|
|
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
CRSP / CRISPR Therapeutics AG
|
|
|
|
|
|
|
|
MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
ALLO / Allogene Therapeutics, Inc.
|
|
|
|
|
|
|
|
DNLI / Denali Therapeutics Inc.
|
|
|
|
|
|
|
|
SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
DMTK / DermTech, Inc.
|
|
|
|
|
|
|
|
RXRX / Recursion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
SANA / Sana Biotechnology, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation
|
|
|
|
|
|
|
|
VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
OMIC / Singular Genomics Systems, Inc.
|
|
|
|
|
|
|
|
KRON / Kronos Bio, Inc.
|
|
|
|
|
|
|
|
RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
BLFS / BioLife Solutions, Inc.
|
|
|
|
|
|
|
|